Novagant’s CBD Transdermal Patch to Provide Localized Delivery

Novagant Corp recently announced that it has found the best carrier for the localized delivery of Cannabidiol (CBD).

Novagant said that the main challenges have been the low absorption rate of the carrier oil. The company dubbed the CBD transdermal patch a breakthrough for localized delivery. By avoiding the effects on the gastrointestinal tract and first-pass metabolism seen with some oral delivery, transdermal patch therapies can enhance therapeutic efficacy, while decreasing side effects.

Transdermal patches can provide localized delivery to the exact area where the Cannabinoids are needed. Additionally, transdermal delivery prevents the metabolization of tetrahydrocannabinol (THC) into fatty tissues, even though the legal industrial hemp oil contains very small amounts of THC, with less than one percent by volume. CBD is a non-psychoactive component of cannabis and therefore does not provide users with the feeling of being “high.” It has been shown to have various therapeutic benefits.

Novagant’s new patch formula will be based on the GoldenCBD oil extract, which is a 100 natural and derived from the federally-legal industrial hemp plant. According to the company, combining Novagant’s unique hemp cultivars with its proprietary technologies produce the highest quality CBD-rich hemp oil in the world.

Novagant said that it is 90 days away from its first test batch of patches for internal testing.

Source: Novagant Corp.

Last updated: 10/30/14; 11:20am EST